Centene's Quarterly Earnings Forecast: Analysts Predict Drop in Q2 2025 EPS

Centene Corporation, a healthcare enterprise, serves under-insured and uninsured populations. It operates in Medicaid, Medicare, Commercial, and Specialty Services sectors, offering diverse healthcare solutions nationwide. Analysts expect a 28.9% drop in Q2 2025 adjusted EPS to $1.72. For fiscal 2025, EPS is predicted to dip to $6.46 but rise to $6.91 in fiscal 2026. Shares have fallen 50% in the past year, underperforming indices. Despite exceeding Q1 2025 earnings estimates, Centene’s stock dropped due to increased Medicaid costs. Analysts have a “Moderate Buy” rating on the stock, with a target price below $66.81.

Read more at Yahoo Finance: What to Expect From Centene’s Next Quarterly Earnings Report